1. Short title
This Act may be cited as the “Stem Cell Therapeutic and Research Reauthorization Act of 2019”.
Stem Cell Therapeutic and Research Reauthorization Act of 2019
A BILL
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.
2. Reauthorization of the C.W. Bill Young Cell Transplantation Program
In general— Section 379(d)(2)(B) of the Public Health Service Act (42 U.S.C. 274k(d)(2)(B)) is amended—
by striking “including remote collection, consistent with the inventory” and inserting “including collection, consistent with the inventory”; and
by inserting “including remote collection,” before “consistent with the requirements”.
Advisory council meetings— Subsection (a) of section 379 of the Public Health Service Act (42 U.S.C. 274k) is amended by adding at the end the following new paragraph:
“(7) The Secretary shall convene the Advisory Council at least two times each calendar year.”
Authorization of appropriations— Section 379B of the Public Health Service Act (42 U.S.C. 274m) is amended by striking “$33,000,000 for fiscal year 2015 and $30,000,000 for each of fiscal years 2016 through 2020” and inserting “$30,000,000 for each of fiscal years 2020 through 2024”.
3. Cord blood inventory
Subsection (g) of section 2 of the Stem Cell Therapeutic and Research Act of 2005 (42 U.S.C. 274k note) is amended to read as follows:
“(g) Authorization of appropriations—To carry out this section, there is authorized to be appropriated $23,000,000 for each of fiscal years 2020 through 2024.”